Does acute treatment of dapagliflozin reduce cardiac infarct size through direct cardiac effects or reductions in blood glucose levels?
Coert J ZuurbierPublished in: Cardiovascular diabetology (2020)
Keyphrases
- blood glucose
- left ventricular
- liver failure
- glycemic control
- acute myocardial infarction
- respiratory failure
- blood pressure
- type diabetes
- heart failure
- drug induced
- metabolic syndrome
- aortic dissection
- hepatitis b virus
- percutaneous coronary intervention
- replacement therapy
- insulin resistance
- extracorporeal membrane oxygenation
- smoking cessation